Denise M. Bohnert insider trades: Amedisys (AMED) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Denise reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 23, 2022 | AMED | ↓ Sell | 557 | $115.00 | $64K | Direct | Jun 27, 2022 (4d) |
| Feb 25, 2021 | AMED | ↓ Sell | 70 | $274.44 | $19K | Direct | Mar 1, 2021 (4d) |
| Feb 22, 2021 | AMED | ↓ Sell | 126 | $291.48 | $37K | Direct | Feb 23, 2021 (1d) |
| Jan 25, 2021 | AMED | ↓ Sell | 454 | $314.41 | $143K | Direct | Jan 27, 2021 (2d) |
| Jan 20, 2021 | AMED | ↓ Sell | 526 | $300.84 | $158K | Direct | Jan 22, 2021 (2d) |
| Jul 29, 2020 | AMED | ↓ Sell | 362 | $220.00 | $80K | Direct | Jul 31, 2020 (2d) |
| Jun 2, 2020 | AMED | ↓ Sell | 263 | $190.36 | $50K | Direct | Apr 22, 2021 (324d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Denise M. Bohnert's insider trades
Denise M. Bohnert is Chief Compliance Officer at Amedisys (AMED). Since Jun 2, 2020, Denise has reported no open-market purchases and 7 sales worth $551K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (16 filings), option exercises (6 filings), grants and awards (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.